Gorsh, Amy
Mayo Clinic
Division of Laboratory Medicine and Pathology, Mayo Clinicgrid.66875.3a, Rochester, Minnesota, USA.
Citations 1
Limited Correlation between SARS-CoV-2 Serologic Assays for Identification of High-Titer COVID-19 Convalescent Plasma Using FDA Thresholds
Larkey, Nicholas E., Ewaisha, Radwa , Lasho, Michael A., Roforth, Matthew M., Granger, Dane, Jerde, Calvin R. , Gorsh, Amy P., Klassen, Stephen A. , Senefeld, Jonathon W. , Joyner, Michael J. , Baumann, N, Theel, Elitza S. , Mills, John R. , Wu, Liang, Gorsh, Amy, Baumann, Nikola A, Theel, Elitza S , Mills, J R , Joyner, Michael J , Senefeld, Jonathon W , Klassen, Stephen A , Wu, Liang Li
Microbiology Spectrum | July 5, 2022 | Volume: 10 | Issue: 4 | Pages: No page available
COVID-19 convalescent plasma (CCP) was one of the first therapeutic options available for the treatment of SARS-CoV-2 infections and continues to be used selectively for immunosuppressed patients. Given the emergence of novel SARS-CoV-2 variants which are resistant to treatment with available monoclonal antibody (MAb) therapy, CCP remains an important therapeutic consideration.